Topic:AdvancesinCardio-Oncology:reviewofstate-of-the-artclinicalpracticeandfuturedirections
TheSpecialIssueiseditedbyGuestEditors:
Mainpurpose
Wewillreviewtheadvancesinthepreventionandtreatmentofcardiovasculardiseasesincancerpatientsbeforeandduringcancertherapy.Strategiestoimprovecardiovascularoutcomesincancersurvivorswillbeexplored.Cardio-Oncologyclinicalcaseswillbepresented.Wewelcomeoriginalresearch,reviewarticles,perspective/opinion,andcasereports,relatedtoCardio-Oncology.
Outlineofpathways
1.OverviewofthefieldofCardio-Oncology:Definition,epidemiologyofcardiotoxicityandtheroleofmultidisciplinarycareteam
2.Addressingcardiovascularriskfactorsincancerpatients
3.Cardiotoxicityassociatedwithchemotherapydrugssuchasanthracyclines,targeteddrugs,endocrinedrugs,andradiotherapy,etal.Inparticular,short-andlong-termcardiovascularresponsesinducedbyimmunecheckpointinhibitors
4.ALamyloidosis,SCTandimpactonthecardiovascularsystem
5.Cardio-Oncologytrainingstatus
6.FutureofthefieldofCardio-Oncology
Wordslimit
Forotherarticletypes,pleaserefertoauthor’sinstructions:
AcceptedpaperswillbepublishedcontinuouslyintheCardiologyPlus(assoonasaccepted)andwillbelistedtogetherontheSpecialIssuewebsite.
CardiologyPlussubmissionsystem:
Pleaseindicateinthecoverletterthatyourarticleisfor“AdvancesinCardio-Oncology:reviewofstate-of-the-artclinicalpracticeandfuturedirections”.ThesubmissiondeadlineisMarch31,2025.Wearelookingforwardtoyourcontribution!